IP Library Granted Patent US 10,568,501
Granted Patent B2
US 10,568,501 · App. 16/030,104 · Granted Feb 25, 2020

Apparatus for modelling ocular structures

Inventors: Daniel Boss (Zurich, CH); Michael Mrochen (Eglisau, CH); Andrew Nolan (Louth, IE); Pav Zakharov (Volketswil, CH)
Assignee: Novartis AG
A61B3/0025A61B3/102A61B3/103A61B3/113G01B9/02091
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,568,501
App. No.
16/030,104
Granted
Feb 25, 2020
Kind
B2
Abstract

An apparatus for motion compensated modelling of a parameter of an eye, comprising: a first measuring means for measuring a plurality of position parameters of the eye with respect to an optical reference coordinate system of the apparatus; a second measuring means for measuring an interference signal at a plurality of optical reference coordinates, wherein the measurement of the plurality of position parameters and measurement of the interference signal are time synchronised; means for correcting the interference signal to account for a displacements of a parameter of the plurality of position parameters; and means for modelling the eye parameter based at least in part on the corrected interference signal.

Claims (17)

1. An apparatus for motion compensated modelling of a parameter of an eye, comprising:

a light source for illuminating a targeted ocular surface with a least one incident light beam and directing at least two light beams returning from the illuminated targeted ocular surface to an image forming device;

an imaging device for measuring a plurality of position parameters of the eye with respect to an optical reference coordinate system of the apparatus based on an image formed in the image forming device;

an Optical Coherence Tomography (OCT) device for directing an OCT imaging beam at the targeted ocular surfaces for measuring an interference signal associated with the OCT imaging beam at a plurality of optical reference coordinates, wherein the measurement of the plurality of position parameters and measurement of the interference signal are time synchronized;

a controller comprising a processor and a computer-readable containing instructions which, when executed by the processor, cause the controller to correct the interference signal to account for a displacements of a parameter of the plurality of position parameters and modelling the eye parameter based at least in part on the corrected interference signal.

2. The apparatus according to claim 1 , wherein the plurality of position parameters include one or more of a lateral displacement along an x axis of the optical reference coordinate system, lateral displacement along a y axis of the optical reference coordinate system and axial displacement along a z axis of the optical reference coordinate system.

3. The apparatus according to claim 1 , wherein the plurality of position parameters include cyclorotation around the z-axis.

4. The apparatus according to claim 1 , wherein the plurality of position parameters include rotation around the x axis and rotation around the y axis.

5. The apparatus according to claim 1 , wherein measuring a plurality of position parameters includes interpolating between measurements of the plurality of position parameters.

6. The apparatus according to claim 1 , wherein the instructions further cause the controller to determine a reference location of the second measuring device and correct said reference location based on the measured position parameters.

7. The apparatus according to claim 1 , wherein the instructions further cause the controller to correct an optical path length based on a difference in an optical path length between an off-axis ray-traced path length and a path length along the z axis of the optical reference coordinate system.

8. The apparatus according to claim 1 , wherein the imaging device measures a position parameter based on a retinal reflex.

9. The apparatus according to claim 7 , wherein the instructions further cause the controller to iteratively correct the optical path length.

10. The apparatus according to claim 1 , wherein the ocular surface includes one or more of an anterior corneal surface, a posterior corneal surface, an anterior lens surface, a posterior lens surface or a retinal surface.

11. The apparatus according to claim 10 , wherein the imaging device is selected from a list including a Purkinje Mirror Imaging device, an Optical coherence Tomography Device or a Scheimpflug Imaging System.

12. The apparatus according to claim 10 , wherein the instructions further cause the controller to determine refraction at the ocular surface and correct the modelled eye parameter based on the determined refraction.

13. The apparatus of claim 12 , wherein the instructions further cause the controller to correct the interference signal to account for a displacement of a parameter of the plurality of position parameters by correcting for an optical path difference associated with the interference signal using the determined refraction.

Assignments (6)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2018
From: CLEARSIGHT INNOVATIONS LIMITED
To: ALCON PHARMACEUTICALS, LIMITED
Reel/Frame 046935/0281 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2018
From: ALCON PHARMACEUTICALS, LIMITED
To: NOVARTIS AG
Reel/Frame 046935/0315 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2018
From: ZAKHAROV, PAVEL; BOSS, DANIEL; MROCHEN, MICHAEL; NOLAN, ANDREW
To: CLEARSIGHT INNOVATIONS LIMITED
Reel/Frame 047128/0487 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 6, 2018
From: CLEARSIGHT INNOVATIONS LIMITED
To: ALCON PHARMACEUTICALS, LIMITED
Reel/Frame 046808/0307 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 6, 2018
From: ALCON PHARMACEUTICALS, LIMITED
To: NOVARTIS AG
Reel/Frame 046808/0389 →
Priority Claims (1)
EP 15163726 · Apr 15, 2015 · regional
Continuity (2)
Continuation 15091615 · Apr 6, 2016
Related Publication 20180310819A1 · Nov 1, 2018
Cited By (3)
US 12,232,810 US 12,290,317 US 12,396,639